MPM Oncology Impact Management

MPM BioImpact as of Sept. 30, 2023

Portfolio Holdings for MPM BioImpact

MPM BioImpact holds 32 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cullinan Oncology Common (CGEM) 18.5 $69M 7.6M 9.05
Olema Pharmaceuticals Common (OLMA) 6.1 $23M 1.9M 12.35
Geron Corporation Common (GERN) 6.1 $23M 11M 2.12
Repare Therapeutics Common (RPTX) 5.3 $20M 1.6M 12.08
iTeos Therapeutics Common 5.1 $19M 1.7M 10.95
Intellia Therapeutics Common (NTLA) 4.6 $17M 545k 31.62
Moonlake Immunotherapeutics Common (MLTX) 4.5 $17M 294k 57.00
Iovance Biotherapeutics Common (IOVA) 4.0 $15M 3.3M 4.55
Crinetics Pharmaceuticals Common (CRNX) 3.8 $14M 479k 29.74
Insmed Incorporated Common (INSM) 3.6 $13M 528k 25.25
Structure Therapeutics Common (GPCR) 3.1 $12M 231k 50.42
Verve Therapeutics Common (VERV) 3.0 $11M 858k 13.26
Relay Therapeutics Common (RLAY) 3.0 $11M 1.4M 8.41
Regenxbio Common (RGNX) 2.9 $11M 657k 16.46
Cymabay Therapeutics Common 2.4 $9.1M 611k 14.91
Karuna Therapeutics Common 2.4 $9.0M 53k 169.09
Amicus Therapeutics Common (FOLD) 2.3 $8.7M 716k 12.16
Revolution Medicines Common (RVMD) 2.0 $7.6M 273k 27.68
Xeris Biopharma Holdings Common (XERS) 2.0 $7.4M 4.0M 1.86
Avadel Pharmaceuticals Common 1.8 $6.8M 664k 10.30
Axsome Therapeutics Common (AXSM) 1.7 $6.5M 94k 69.89
Madrigal Pharmaceuticals Common (MDGL) 1.6 $6.0M 41k 146.04
Kalvista Pharmaceuticals Common (KALV) 1.5 $5.6M 578k 9.63
Werewolf Therapeutics Common (HOWL) 1.4 $5.1M 2.4M 2.14
Travere Therapeutics Common (TVTX) 1.3 $4.9M 553k 8.94
Morphic Holding Common (MORF) 1.2 $4.6M 200k 22.91
Adaptimmune Therapeutics Sponsored ADR (ADAP) 1.1 $4.0M 5.1M 0.78
Viridian Therapeutics Common (VRDN) 1.0 $3.9M 255k 15.34
Phathom Pharmaceuticals Common (PHAT) 1.0 $3.6M 347k 10.37
Viking Therapeutics Common (VKTX) 1.0 $3.6M 325k 11.07
Inozyme Pharma Common (INZY) 0.4 $1.4M 327k 4.20
Harpoon Therapeutics Common 0.3 $1.3M 320k 4.03